title: Exercise and mild essential hypertension.
abstract: The achievement of chronic blood pressure (BP) control in persons with mild hypertension is of central strategic concern in the prevention of hypertension-related morbidity and mortality. Epidemiologic and longitudinal studies suggest that regular participation in physical activity may be beneficial both in preventing hypertension and in lowering an already elevated BP. Moreover, preliminary analyses from our center suggest that cardiorespiratory fitness and, by inference, aerobic exercise may be of benefit in reducing mortality rates in hypertensive patients. When prescribing exercise with the intention of reducing an elevated BP and attenuating the risk for coronary artery disease, several factors must be considered to optimize the likelihood of a safe and effective response. These factors include specific safety aspects, and the type, frequency, intensity, and duration of exercise. In this respect, we recommend that aerobic exercise be performed at an intensity corresponding to 55 and 85% of the maximal heart rate and that the duration and frequency of training be modulated to achieve a weekly energy expenditure of between 14 and 20 kcal/kg of body weight. For those patients who require drug therapy, the interaction between the specific antihypertensive agent and exercise must also be considered.
authors.affiliation: Institute for Aerobics Research, Dallas, Texas.
authors.forename: N F
authors.initials: NF
authors.lastname: Gordon
authors.forename: C B
authors.initials: CB
authors.lastname: Scott
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D001676:Biofeedback, Psychology; D002985:Clinical Protocols / Q000592:standards; D002986:Clinical Trials as Topic; D004038:Diet, Reducing / Q000592:standards; D004039:Diet, Sodium-Restricted / Q000592:standards; D005081:Exercise Therapy / Q000379:methods / Q000592:standards*; D006439:Hemodynamics; D006801:Humans; D006973:Hypertension / Q000145:classification / Q000503:physiopathology / Q000628:therapy*; D012064:Relaxation Therapy / Q000592:standards; D012449:Safety; D014891:Weight Lifting / Q000592:standards
chemical_list: D000959:Antihypertensive Agents